Počet záznamů: 1  

Antioxidant defense in quiescent cells determines selectivity of electron transport chain inhibition-induced cell death

  1. 1.
    SYSNO ASEP0481503
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevAntioxidant defense in quiescent cells determines selectivity of electron transport chain inhibition-induced cell death
    Tvůrce(i) Blecha, Jan (BTO-N)
    Novais, Silvia Magalhaes (BTO-N)
    Rohlenová, Kateřina (BTO-N) ORCID, RID
    Novotná, Eliška (BTO-N)
    Lettlová, Sandra (BTO-N)
    Schmitt, S. (DE)
    Zischka, H. (DE)
    Neužil, Jiří (BTO-N) RID
    Rohlena, Jakub (BTO-N) RID, ORCID
    Celkový počet autorů9
    Zdroj.dok.Free Radical Biology and Medicine. - : Elsevier - ISSN 0891-5849
    Roč. 112, NOV 2017 (2017), s. 253-266
    Poč.str.14 s.
    Jazyk dok.eng - angličtina
    Země vyd.US - Spojené státy americké
    Klíč. slovaElectron transport chain ; Supercomplexes ; Antioxidant defense ; SOD2
    Vědní obor RIVEB - Genetika a molekulární biologie
    Obor OECDBiochemistry and molecular biology
    CEPGA16-22823S GA ČR - Grantová agentura ČR
    GA17-20904S GA ČR - Grantová agentura ČR
    GA16-12719S GA ČR - Grantová agentura ČR
    NV16-31604A GA MZd - Ministerstvo zdravotnictví
    LM2015062 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    LQ1604 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    ED1.1.00/02.0109 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Institucionální podporaBTO-N - RVO:86652036
    UT WOS000411829300022
    EID SCOPUS85026789016
    DOI10.1016/j.freeradbiomed.2017.07.033
    AnotaceMitochondrial electron transport chain (ETC) targeting shows a great promise in cancer therapy. It is particularly effective in tumors with high ETC activity where ETC-derived reactive oxygen species (ROS) are efficiently induced. Why modern ETC-targeted compounds are tolerated on the organismal level remains unclear. As most somatic cells are in non-proliferative state, the features associated with the ETC in quiescence could account for some of the specificity observed. Here we report that quiescent cells, despite increased utilization of the ETC and enhanced supercomplex assembly, are less susceptible to cell death induced by ETC disruption when glucose is not limiting. Mechanistically, this is mediated by the increased detoxification of ETC-derived ROS by mitochondrial antioxidant defense, principally by the superoxide dismutase 2 thioredoxin axis. In contrast, under conditions of glucose limitation, cell death is induced preferentially in quiescent cells and is correlated with intracellular ATP depletion but not with ROS. This is related to the inability of quiescent cells to compensate for the lost mitochondrial ATP production by the upregulation of glucose uptake. Hence, elevated ROS, not the loss of mitochondrially-generated ATP, are responsible for cell death induction by ETC disruption in ample nutrients condition, e.g. in well perfused healthy tissues, where antioxidant defense imparts specificity. However, in conditions of limited glucose, e.g. in poorly perfused tumors, ETC disruption causes rapid depletion of cellular ATP, optimizing impact towards tumor-associated dormant cells. In summary, we propose that antioxidant defense in quiescent cells is aided by local glucose limitations to ensure selectivity of ETC inhibition-induced cell death.
    PracovištěBiotechnologický ústav
    KontaktMonika Kopřivová, Monika.Koprivova@ibt.cas.cz, Tel.: 325 873 700
    Rok sběru2018
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.